JPMorgan Global Growth & Income (LON:JGGI - Get Free Report) shares reached a new 52-week high during mid-day trading on Thursday . The stock traded as high as GBX 585 ($7.62) and last traded at GBX 581 ($7.56), with a volume of 452165 shares trading hands. The stock had previously closed at GBX 580 ($7.55).
JPMorgan Global Growth & Income Price Performance
The business's 50 day moving average price is GBX 558.36 and its 200 day moving average price is GBX 559.79. The stock has a market capitalization of £2.89 billion, a P/E ratio of 674.71 and a beta of 0.61. The company has a debt-to-equity ratio of 6.71, a current ratio of 30.12 and a quick ratio of 5.88.
Insider Buying and Selling at JPMorgan Global Growth & Income
In other news, insider Sarah Whitney purchased 3,882 shares of the business's stock in a transaction on Friday, October 25th. The stock was acquired at an average cost of GBX 576 ($7.50) per share, for a total transaction of £22,360.32 ($29,107.42). 7.92% of the stock is owned by corporate insiders.
About JPMorgan Global Growth & Income
(
Get Free Report)
JPMorgan Global Growth & Income plc is a closed-ended equity mutual fund launched and managed by JPMorgan Funds Limited. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating across diversified sectors. The fund primarily invests in growth stocks of companies across all market capitalizations, with a bias towards large cap companies.
Recommended Stories
Before you consider JPMorgan Global Growth & Income, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and JPMorgan Global Growth & Income wasn't on the list.
While JPMorgan Global Growth & Income currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
